Dry eye is common in children with JRA

Article

Dry eye is common in children with juvenile rheumatoid arthritis (JRA).

Dry eye is common in children with juvenile rheumatoid arthritis (JRA), reveals an investigation in the European Journal of Ophthalmology.

Dr Amany Abdel-Fattah El-Shazly et al., Department of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt, conducted an evaluation into dry eye on 40 patients with JRA.

The study consisted of 28 girls and 12 boys between the ages of 7 and 12 years. Each patient underwent medical history, clinical examination and a full ophthalmologic evaluation.

Tear filrm break-up time, Schirmer-1 test and corneal fluorescein staining were to test for dry eye. The control gropu consisted of 20 healthy age and sex-matched children.

The results demonstrated that 30 patients presented with consistent findings with dry eye diagnosis. First-degree dryness was found in 20 patients, second-degree dryness in 8 patients and 2 had third-degree dryness.

Dry eye severity tended to be significantly lower in remission, compared to amount of disease activity. The only factor that seemed to affect dry eye parameters was the duration of the disease.

The study authors suggest that all children with JRA should be screened for dry eye as the severity of dry eye is highly correlated with disease activity.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.